Coordinated translational control of multiple immune checkpoints by the integrated stress response pathway in lung

Shayna Thomas-Jardin1, Shruthy Suresh1,2,3, Ariana Arce1

  • 1Department of Molecular Biology, UT Southwestern Medical Center, Dallas, TX, USA.

Insights

The integrated stress response (ISR) pathway promotes cancer immune evasion by upregulating PD-L1 and CD155. Inhibiting the ISR enhances anti-cancer immunity, offering a new therapeutic strategy for lung cancer.

Area of Science:

  • Cancer immunology
  • Molecular biology
  • Tumor microenvironment

Background:

  • The integrated stress response (ISR) is crucial for cancer cell survival under stress.
  • ISR activation leads to Programmed Death Ligand 1 (PD-L1) induction, suppressing anti-tumor immunity.
  • Tumor immune escape mechanisms involve multiple immune checkpoint proteins.

Purpose of the Study:

  • To identify additional immune checkpoint proteins regulated by the ISR.
  • To elucidate the mechanisms of ISR-mediated tumor immune escape.
  • To explore novel therapeutic strategies for lung cancer.

Main Methods:

  • Analysis of ISR-regulated gene expression and protein translation.
  • Investigating the role of upstream open reading frames (uORFs) in 5' UTRs.
  • Correlative analysis of PD-L1 and CD155 expression in primary human lung tumors.
  • Evaluating the efficacy of combined PD-1 blockade and ISR inhibition (ISRIB) in preclinical models.

Main Results:

  • The ISR coordinately induces both PD-L1 and CD155 expression.
  • ISR activation enhances the translation of PD-L1 and CD155 by bypassing inhibitory uORFs.
  • A significant correlation between PD-L1 and CD155 expression was observed in human lung tumors.
  • ISR activation accelerates tumorigenesis and impairs T cell function.
  • Combined PD-1 blockade and ISR inhibition overcome these effects.

Conclusions:

  • The ISR represents a novel regulatory mechanism for coordinated immune checkpoint protein expression.
  • The ISR pathway is a therapeutic vulnerability in lung cancer.
  • Combining PD-1 blockade with ISR inhibition presents a promising new therapeutic strategy for lung cancer patients.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
24
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K